Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
BDX vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
BDX vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Biotechnology |
| Market Cap | $52.23B | $1669.52T |
| Revenue (TTM) | $21.92B | $0.00 |
| Net Income (TTM) | $1.76B | $-168M |
| Gross Margin | 45.8% | — |
| Operating Margin | 12.4% | — |
| Forward P/E | 11.5x | — |
| Total Debt | $19.18B | $22M |
| Cash & Equiv. | $851M | $194M |
BDX vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Becton, Dickinson a… (BDX) | 100 | 96.9 | -3.1% |
| DBV Technologies S.… (DBVT) | 100 | 40.2 | -59.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BDX vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BDX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.66, yield 2.9%
- Rev growth 8.2%, EPS growth -0.5%, 3Y rev CAGR 5.0%
- 72.0% 10Y total return vs DBVT's -87.1%
DBVT is the clearest fit if your priority is momentum.
- +110.7% vs BDX's +43.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.2% revenue growth vs DBVT's -100.0% | |
| Quality / Margins | 8.0% margin vs DBVT's 0.3% | |
| Stability / Safety | Beta 0.66 vs DBVT's 1.26 | |
| Dividends | 2.9% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +110.7% vs BDX's +43.1% | |
| Efficiency (ROA) | 3.2% ROA vs DBVT's -89.0% |
BDX vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BDX vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
BDX and DBVT operate at a comparable scale, with $21.9B and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $21.9B | $0 |
| EBITDAEarnings before interest/tax | $5.2B | -$112M |
| Net IncomeAfter-tax profit | $1.8B | -$168M |
| Free Cash FlowCash after capex | $2.6B | -$151M |
| Gross MarginGross profit ÷ Revenue | +45.8% | — |
| Operating MarginEBIT ÷ Revenue | +12.4% | — |
| Net MarginNet income ÷ Revenue | +8.0% | — |
| FCF MarginFCF ÷ Revenue | +12.0% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.6% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +28.8% | +91.5% |
Valuation Metrics
DBVT leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $52.2B | $1669.52T |
| Enterprise ValueMkt cap + debt − cash | $70.6B | $1669.52T |
| Trailing P/EPrice ÷ TTM EPS | 24.73x | -0.74x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.54x | — |
| PEG RatioP/E ÷ EPS growth rate | 1.49x | — |
| EV / EBITDAEnterprise value multiple | 14.00x | — |
| Price / SalesMarket cap ÷ Revenue | 2.39x | — |
| Price / BookPrice ÷ Book value/share | 1.63x | 0.64x |
| Price / FCFMarket cap ÷ FCF | 19.56x | — |
Profitability & Efficiency
BDX leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
BDX delivers a 6.9% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-130 for DBVT. DBVT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to BDX's 0.76x. On the Piotroski fundamental quality scale (0–9), BDX scores 7/9 vs DBVT's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.9% | -130.2% |
| ROA (TTM)Return on assets | +3.2% | -89.0% |
| ROICReturn on invested capital | +4.3% | — |
| ROCEReturn on capital employed | +5.4% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.76x | 0.13x |
| Net DebtTotal debt minus cash | $18.3B | -$172M |
| Cash & Equiv.Liquid assets | $851M | $194M |
| Total DebtShort + long-term debt | $19.2B | $22M |
| Interest CoverageEBIT ÷ Interest expense | 4.65x | -189.82x |
Total Returns (Dividends Reinvested)
DBVT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BDX five years ago would be worth $10,602 today (with dividends reinvested), compared to $3,041 for DBVT. Over the past 12 months, DBVT leads with a +110.7% total return vs BDX's +43.1%. The 3-year compound annual growth rate (CAGR) favors DBVT at 5.7% vs BDX's -0.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -5.2% | +2.3% |
| 1-Year ReturnPast 12 months | +43.1% | +110.7% |
| 3-Year ReturnCumulative with dividends | -1.7% | +18.1% |
| 5-Year ReturnCumulative with dividends | +6.0% | -69.6% |
| 10-Year ReturnCumulative with dividends | +72.0% | -87.1% |
| CAGR (3Y)Annualised 3-year return | -0.6% | +5.7% |
Risk & Volatility
Evenly matched — BDX and DBVT each lead in 1 of 2 comparable metrics.
Risk & Volatility
BDX is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBVT currently trades 74.4% from its 52-week high vs BDX's 70.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.66x | 1.26x |
| 52-Week HighHighest price in past year | $205.52 | $26.18 |
| 52-Week LowLowest price in past year | $100.31 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +70.1% | +74.4% |
| RSI (14)Momentum oscillator 0–100 | 33.3 | 43.7 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 249K |
Analyst Outlook
BDX leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates BDX as "Buy" and DBVT as "Buy". Consensus price targets imply 137.7% upside for DBVT (target: $46) vs 19.9% for BDX (target: $173). BDX is the only dividend payer here at 2.89% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $172.85 | $46.33 |
| # AnalystsCovering analysts | 33 | 15 |
| Dividend YieldAnnual dividend ÷ price | +2.9% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | $4.17 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.9% | 0.0% |
DBVT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). BDX leads in 2 (Profitability & Efficiency, Analyst Outlook). 1 tied.
BDX vs DBVT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is BDX or DBVT a better buy right now?
Becton, Dickinson and Company (BDX) offers the better valuation at 24.
7x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate Becton, Dickinson and Company (BDX) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BDX or DBVT?
Over the past 5 years, Becton, Dickinson and Company (BDX) delivered a total return of +6.
0%, compared to -69. 6% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: BDX returned +72. 0% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BDX or DBVT?
By beta (market sensitivity over 5 years), Becton, Dickinson and Company (BDX) is the lower-risk stock at 0.
66β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 91% more volatile than BDX relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 76% for Becton, Dickinson and Company — giving it more financial flexibility in a downturn.
04Which is growing faster — BDX or DBVT?
On earnings-per-share growth, the picture is similar: Becton, Dickinson and Company grew EPS -0.
5% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BDX or DBVT?
Becton, Dickinson and Company (BDX) is the more profitable company, earning 7.
7% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 7. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BDX leads at 11. 8% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — BDX leads at 45. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is BDX or DBVT more undervalued right now?
Analyst consensus price targets imply the most upside for DBVT: 137.
7% to $46. 33.
07Which pays a better dividend — BDX or DBVT?
In this comparison, BDX (2.
9% yield) pays a dividend. DBVT does not pay a meaningful dividend and should not be held primarily for income.
08Is BDX or DBVT better for a retirement portfolio?
For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
66), 2. 9% yield). Both have compounded well over 10 years (BDX: +72. 0%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BDX and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
BDX pays a dividend while DBVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.